pirbuterol has been researched along with Hypokalemia in 2 studies
pirbuterol: structure
Hypokalemia: Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Windom, H | 1 |
| Grainger, J | 1 |
| Burgess, C | 1 |
| Crane, J | 1 |
| Pearce, N | 1 |
| Beasley, R | 1 |
| Raimondi, G | 1 |
| Rodriguez-Moncalvo, JJ | 1 |
1 trial available for pirbuterol and Hypokalemia
| Article | Year |
|---|---|
A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Bronchodilator Agents; Dose- | 1990 |
1 other study available for pirbuterol and Hypokalemia
| Article | Year |
|---|---|
Effects of beta-adrenergic agents on hypokalemia.
Topics: Adrenergic beta-Agonists; Ethanolamines; Humans; Hypokalemia; Lung Diseases, Obstructive; Potassium | 1987 |